XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary

Go back to XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
(NASDAQ: XAIR) Delayed: 4.48 --0 (-0%)
Previous Close $4.48    52 Week High
Open $4.48    52 Week Low
Day High $4.48    P/E N/A 
Day Low $4.48    EPS
Volume 7,195,127       

XTL BIOPHARM SP ADR (NASDAQ: XTLB) Delayed: 2.47 --0 (-0%)
Previous Close $2.47    52 Week High $1.75 
Open $2.47    52 Week Low $0.64 
Day High $2.47    P/E N/A 
Day Low $2.47    EPS $0.00 
Volume 221